We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+8.86%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$141M
AUM Growth
+$23.2M
Cap. Flow
+$19.2M
Cap. Flow %
13.6%
Top 10 Hldgs %
39.69%
Holding
74
New
8
Increased
33
Reduced
5
Closed
4

Top Buys

Rank Stock Value
1
TLGT
Teligent, Inc
TLGT
+$4.57M
2
HBIO icon
Harvard Bioscience
HBIO
+$4.38M
3
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
+$3.79M
4
ENZ
Enzo Biochem, Inc.
ENZ
+$3.61M
5
TECH icon
Bio-Techne
TECH
+$3.05M

Top Sells

Rank Stock Value
1
TEAR
TearLab Corporation
TEAR
+$4.75M
2
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$3.31M
3
ACCL
Accelrys Inc
ACCL
+$2.99M
4
ATRC icon
AtriCure
ATRC
+$2.86M
5
ARTC
ARTHROCARE CORP
ARTC
+$1.77M

Sector Composition

Rank Sector Weight
1 Healthcare 85.86%
2 Consumer Staples 2.17%
3 Financials 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NXTM
26
DELISTED
NxStage Medical Inc.
NXTM
$2.24M 1.59%
+175,655
New +$2.29M
ABCO
27
DELISTED
Advisory Board Co
ABCO
$2.14M 1.52%
33,327
+4,777
+17% +$303K
HSTM icon
28
HealthStream
HSTM
$819M
$1.87M 1.32%
69,891
+10,064
+17% +$299K
LMAT icon
29
LeMaitre Vascular
LMAT
$2.32B
$1.8M 1.28%
223,409
+34,003
+18% +$272K
ALGN icon
30
Align Technology
ALGN
$12.1B
$1.62M 1.15%
31,346
+4,236
+16% +$237K
SGNT
31
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$1.52M 1.07%
64,856
+9,237
+17% +$202K
CYTK icon
32
Cytokinetics
CYTK
$10.5B
$1.46M 1.03%
153,338
+22,887
+18% +$207K
MASI
33
DELISTED
Masimo
MASI
$1.42M 1%
51,865
+7,214
+16% +$206K
GNMK
34
DELISTED
GenMark Diagnostics, Inc
GNMK
$1.4M 0.99%
141,124
+22,786
+19% +$283K
BMRN icon
35
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.27M 0.9%
18,689
+2,472
+15% +$182K
OREX
36
DELISTED
Orexigen Therapeutics, Inc.
OREX
$1.27M 0.9%
19,536
+2,456
+14% +$166K
COV
37
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$1.25M 0.89%
17,013
+2,434
+17% +$170K
ELGX
38
DELISTED
Endologix Inc
ELGX
$1.13M 0.8%
8,776
+1,202
+16% +$187K
VRTX icon
39
Vertex Pharmaceuticals
VRTX
$121B
$1.06M 0.75%
14,990
+1,971
+15% +$156K
ANGO icon
40
AngioDynamics
ANGO
$611M
$1.01M 0.72%
64,260
+7,397
+13% +$121K
HTWR
41
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$986K 0.7%
10,516
+1,539
+17% +$150K
PETX
42
DELISTED
Aratana Therapeutics, Inc.
PETX
$914K 0.65%
49,263
-5,026
-9% -$101K
THOR
43
DELISTED
THORATEC CORPORATION
THOR
$867K 0.61%
24,204
+2,698
+13% +$96.7K
SURG
44
DELISTED
SYNERGETICS USA, INC.
SURG
$832K 0.59%
272,851
+37,852
+16% +$128K
FRX
45
DELISTED
FOREST LABORATORIES INC
FRX
$704K 0.5%
7,635
– –
VVUS
46
DELISTED
Vivus Inc
VVUS
$693K 0.49%
11,670
+1,903
+19% +$135K
ENDP
47
DELISTED
Endo International plc
ENDP
$626K 0.44%
9,125
– –
NVS icon
48
Novartis
NVS
$297B
$516K 0.37%
6,774
– –
VTRS icon
49
Viatris
VTRS
$20.4B
$477K 0.34%
9,775
– –
BMY icon
50
Bristol-Myers Squibb
BMY
$133B
$431K 0.31%
8,290
– –
1
2
3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, First Light Asset Management held 74 positions worth $141M, up 20% from $118M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

First Light Asset Management deployed $19.2M of net new capital in Q1 2014, opening 8 new positions and adding to 33 existing holdings. Its largest new stake was Teligent, Inc: 113,378 shares worth $6.41M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 76% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was AtriCure, an estimated $2.86M trimmed.

  • First Light Asset Management's largest Q1 2014 buy was Teligent, Inc: 113,378 shares worth $6.41M.
  • First Light Asset Management added most to Streamline Health Solutions in Q1 2014, an estimated $1.67M increase.
  • First Light Asset Management's biggest Q1 2014 reduction was AtriCure, cutting an estimated $2.86M.
  • First Light Asset Management fully exited TearLab Corporation in Q1 2014, selling an estimated $4.75M.
  • First Light Asset Management's ten largest holdings make up 40% of its $141M portfolio in Q1 2014.
  • First Light Asset Management opened 8 new positions and closed 4 in Q1 2014.
  • First Light Asset Management's portfolio value rose 20% quarter-over-quarter to $141M.

Based on First Light Asset Management's 13F filing for Q1 2014, filed 15 May 2014.